We use cookies to improve the performance of our site and optimize it for our users. Customize Cookie Preferences

Sign Up Today and Learn More About Cradle Stock

Invest in or calculate the value of your shares in Cradle or other pre-IPO companies through EquityZen's platform.

Get Started

Cradle Stock (CRAD)

Cradle is a biotech company that uses prediction algorithms and AI design recommendations to assist biologists in designing proteins.

About Cradle Stock

Founded

2021

Industries

Software, Data and Analytics, Science and Engineering

Cradle is a biotech company that uses prediction algorithms and AI design recommendations to assist biologists in designing proteins. Cradle offers complete ownership of the intellectual property while maintaining the privacy and security of your sequences and data. Cradle offers a machine-learning platform that accelerates the development of new therapeutics and bio-based products like enzymes, antibodies, and chemicals. The platform is versatile, supporting various assets and use cases for both pharmaceutical and industrial applications, including enzymes, antibodies, peptides, vaccines, and therapeutic proteins.

Cradle Management

Leadership team at Cradle

Co-Founder & CEO

Stef van Grieken

Co-Founder

Elise de Reus

Locked Features

Join now and verify your accreditation status to gain access to:

  • Cradle Current Valuation
  • Cradle Stock Price
  • Cradle Management
  • Available deals in Cradle and all other companies with relevant Deal Offering documents
  • EquityZen's proprietary data and insights, which may include
    • Cradle Cap Table and Funding History by Share Class and Liquidity Preferences
    • Cradle Revenue and Financials
    • Cradle Highlights
    • Cradle Business Model
    • Cradle Risk Factors
  • Cradle Research Report from SACRA Research
Join Now

Trading Cradle Stock

How to invest in Cradle stock?

Accredited investors can buy pre-IPO stock in companies like Cradle through EquityZen funds. These investments are made available by existing Cradle shareholders who sell their shares on our platform. Typically, these are early employees who need to fund a life event – house, education, etc. Accredited investors are then offered the opportunity to invest in this stock through a fund, like those used by hedge funds serving large investors. While not without risk, investing in private companies can help investors reach goals of portfolio diversification, access to potential growth and high potential return. Learn more about our Guided Investment process here.

How to sell Cradle stock?

Shareholders can sell their Cradle stock through EquityZen's private company marketplace. EquityZen's network includes over 350K accredited investors interested in buying private company stock. Learn more about the easy and guided Shareholder process here.

If I invest, how do I exit my investment?

There are two ways to exit your private company investment on EquityZen's marketplace. The first is if the company has an exit event like an IPO, merger or acquisition. In that case, we will distribute the shares and/or cash to you directly. The second way is through an Express Deal on EquityZen, if eligible. An Express Deal allows you to sell your allocation of private shares in a given private company to another investor on EquityZen's marketplace. More information on Express Deals can be found here and exit information can be found here.

Why choose EquityZen?

Since 2013, the EquityZen marketplace has made it easy to buy and sell shares in private companies. EquityZen brings together investors and shareholders, providing liquidity to early shareholders and private market access to accredited investors. With low investment minimums through our funds and with more than 45K private placements completed across 450+ companies, EquityZen leads the way in delivering "Private Markets for the Public."